Key Takeaways Strategic collaborations and acquisitions are expected to drive growth in high-growth therapeutic areas and partnerships with health systems. Introduction of innovative tests and tech enhancements is anticipated to improve margins and earnings, with initiatives offsetting rising personnel costs.